Evaluation of Quality Of Life after Cardiac Surgery in High-Risk Patients
Background: Conventionally, there is controversy over subjecting high-risk patients to cardiac operations, due to major postoperative complications. Higher survival rates and less morbidity as well as better quality of life can be good predictors of the outcome of surgery. This study evaluates the quality of life before and 12 months after cardiac operations on high-risk patients.
Methods: In this study, the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II was used to separate high-risk patients from others. The quality of life was assessed using the Medical Outcomes Study 36-item Short Form Health Survey (SF-36) before surgery and one year afterward. Based on SF-36, the score for each of the eight different dimensions of the quality of life was quantified; and, their differences between pre-surgery and post-follow up period were analyzed.
Results: 126 high-risk patients were included in this study. The mean age of the patients was 64.29 ± 12.35 years. The median of EuroSCORE II score in these cases was 6.83 (6.04-25.98). The results reveal that the majority of the quality of life dimensions, except mental health, improved significantly after the follow-up period.
Conclusion: Cardiac surgery on high-risk patients can noticeably promote the different aspects of their quality of life; although, such improvements should be considered against surgical complications.
Aaronson NK, Muller M, Cohen PD, et al. 1998. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055-68.nBjorner JB, Thunedborg K, Kristensen TS, Modvig J, Bech P. 1998. The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol 51:991-9.nChalmers J, Pullan M, Fabri B, et al. 2013. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardio-Thorac 43:688-94.nColak Z, Segotic I, Uzun S, Mazar M, Ivancan V, Majeric-Kogler V. 2008. Health related quality of life following cardiac surgery-correlation with EuroSCORE. Eur J Cardio-Thorac 33:72-6.nDi Dedda U, Pelissero G, Agnelli B, De Vincentiis C, Castelvecchio S, Ranucci M. 2013. Accuracy, calibration and clinical performance of the new EuroSCORE II risk stratification system. Eur J Cardio-Thorac 43:27-32.nGeissler HJ, Holzl P, Marohl S, et al. 2000. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardio-Thorac 17:400-6.nGurler S, Gebhard A, Godehardt E, Boeken U, Feindt P, Gams E. 2003. EuroSCORE as a predictor for complications and outcome. Thorac Cardiov Surg 51:73-7.nGuyatt GH, Feeny DH, Patrick DL. 1993. Measuring health-related quality of life. Ann Intern Med 118:622-9.nLoponen P, Luther M, Nissinen J, et al. 2008. EuroSCORE predicts health-related quality of life after coronary artery bypass grafting. Interact Cardio-Thoracic Surg 7:564-8.nMontazeri A, Goshtasebi A, Vahdaninia M, Gandek B. 2005. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 14:875-82.nNajafi M, Sheikhvatan M, Montazeri A, Abbasi SH, Sheikhfatollahi M. 2008. Quality of Life in Coronary Artery Disease: SF-36 Compared to WHOQOL-BREF. J Tehran Univ Heart Center 3:101-6.nNashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-Thorac 16:9-13.nNashef SA, Roques F, Michel P, et al. 2000. Coronary surgery in Europe: comparison of the national subsets of the European system for cardiac operative risk evaluation database. Eur J Cardio-Thorac 17:396-9.nNashef SA, Roques F, Hammill BG, et al. 2002. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardio-Thorac 22:101-5.nNashef SA, Roques F, Sharples LD, et al. 2012. EuroSCORE II. Eur J Cardio-Thorac 41:734-45.nPeric V, Borzanovic M, Jovanovic A, Stolic R, Sovtic S, Trajkovic G. 2005. The relationship between EuroSCORE preoperative risk prediction and quality of life changes after coronary artery by-pass surgery. Interact Cardio-Thorac Surg 4:622-6.nPinna Pintor P, Bobbio M, Colangelo S, Veglia F, Marras R, Diena M. 2003. Can EuroSCORE predict direct costs of cardiac surgery? Eur J Cardio-Thorac 23:595-8.nPitkanen O, Niskanen M, Rehnberg S, Hippelainen M, Hynynen M. 2000. Intra-institutional prediction of outcome after cardiac surgery: comparison between a locally derived model and the EuroSCORE. Eur J Cardio-Thorac 18:703-10.nRiera M, Herrero J, Ibanez J, et al. 2011. Mid-term survival of patients undergoing major cardiac surgery. Rev Esp Cardiol 64:463-9.nRoques F, Michel P, Goldstone AR, Nashef SA. 2003. The logistic EuroSCORE. Eur Heart J 24:881-2.nRumsfeld JS, MaWhinney S, McCarthy M Jr, et al. 1999. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA 281:1298-303.nRumsfeld JS, Magid DJ, O'Brien M, et al. 2001. Changes in health-related quality of life following coronary artery bypass graft surgery. Ann Thorac Surg 72:2026-32.nSampalis J, Boukas S, Liberman M, Reid T, Dupuis G. 2001. Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting. CMAJ 165:429-33.nToumpoulis IK, Anagnostopoulos CE, Swistel DG, DeRose JJ, Jr. 2005. Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur J Cardio-Thorac 27:128-33.nYilmaz M, Saba D, Karal I, et al. 2007. Postoperative outcomes after off-pump coronary artery bypass grafting in EuroSCORE low- and high-risk women. Heart Surg Forum 10:482-6.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).